Merck Vs. GSK: The Game-Changer Race In Pharma Excellence

Friday, 22 September 2023, 18:14:52
Despite the increasing number of emerging challenges for the pharmaceutical industry, the management teams at GSK and Merck are successfully coping with them. Learn which one is best.
— Seeking Alpha

Price Over Earnings Overview: GSK

Friday, 22 September 2023, 17:00:21
In the current session, the stock is trading at $37.73, after a 0.29% spike. Over the past month, GSK Inc. (NYSE: GSK ) stock increased by 8.51% , and in the past year, by 30.92% . With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued. Comparing GSK P/E Against Its Peers The P/E ratio is used by long-term shareholders to assess the company”s market … Full story available on Benzinga.com
— Benzinga

Biotech Stock Roundup: GSK’s Drug Approval, MRNA’s Vaccine News, PTCT & SPRY Down

Friday, 22 September 2023, 04:41:30
It was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates.
— 24/7 Wall street

European Commission authorizes GSK’s HIV prevention drug

Tuesday, 19 September 2023, 22:12:03
close Video Fox News Flash top headlines for September 19 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday. EUROPEAN COMMISSION CHIEF URSULA VON DER LEYEN ASSURES AID TO FLOOD-STRICKEN SLOVENIA DURING VISIT Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 77.16 pounds, according to the company. The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022. (REUTERS/Dado Ruvic/Illustration/File Photo) Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil. CLICK HERE TO GET THE FOX NEWS APP The post European Commission authorizes GSK’s HIV prevention drug appeared first on Samford News .
— Samford Crimson

European Commission authorizes GSK”s HIV prevention drug

Tuesday, 19 September 2023, 21:54:05
The European Commission has granted authorization to GSK”s HIV-focused division, ViiV Healthcare, for its cabotegravir in both long-acting injectable and tablet forms.
— Fox News